Dermatology Doctors in Chicago, IL Accepting Medicare
186 Dermatology doctors found. Showing 61 - 80
 Dr. Jennifer Shastry, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 111 W Washington St Ste 1801, Chicago, IL 60602 Phone: 312-695-8106 Fax: 312-694-1340 |
Keren Horn, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1765 N Elston Ave, Suite 110, Chicago, IL 60642 Phone: 773-276-1100 Fax: 773-276-1102 |
Vesna Petronic-rosic, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1950 W Polk St Fl 4, Chicago, IL 60612 Phone: 312-864-4475 |
Dr. Jordan Claire Carqueville, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 737 N Michigan Ave Ste 720, Chicago, IL 60611 Phone: 312-319-1978 Fax: 312-262-7791 |
Maureen Riegert, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 264, Chicago, IL 60612 Phone: 312-942-2195 |
 David Christopher Reid, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 264, Chicago, IL 60612 Phone: 312-942-2195 |
William Allan Caro, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 676 N Saint Clair St, Suite 1840, Chicago, IL 60611 Phone: 312-266-7180 Fax: 312-587-9001 |
Grace Wei, MD MPH MS Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5841 S Maryland Ave # Mc5067, Chicago, IL 60637 Phone: 773-702-1611 |
Dr. Jerome Mark Garden, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 150 E Huron St Ste 1200, Chicago, IL 60611 Phone: 312-280-0890 Fax: 312-280-9615 |
Dr. Motunrayo Adisa, M.D Dermatology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr Ste 1208, Chicago, IL 60611 Phone: 312-483-4397 |
Dr. Bethanee Jean Schlosser, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 676 North St. Clair Street, Suite 1600, Chicago, IL 60611 Phone: 312-695-8106 |
Adam D Garibay, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1950 W Polk St, Chicago, IL 60612 Phone: 312-864-0200 |
Dr. Maria Mihailescu, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1725 W Harrison St Ste 264, Chicago, IL 60612 Phone: 312-942-2195 |
Dr. Shuai Xu, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 676 N Saint Clair St Ste 1600, Chicago, IL 60611 Phone: 312-695-8106 |
Toral Dilip Patel, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr Ste 930, Chicago, IL 60611 Phone: 312-861-3911 Fax: 312-861-3912 |
Dr. Xiaolong Zhou, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 676 N Saint Clair St Ste 1600, Chicago, IL 60611 Phone: 312-695-8106 Fax: 312-695-0537 |
Kimberly Sable, Dermatology Medicare: Medicare Enrolled Practice Location: 2900 N Lake Shore Dr, Chicago, IL 60657 Phone: 773-665-6730 |
Sarah Jane Adams, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 676 N Saint Clair St Ste 1600, Chicago, IL 60611 Phone: 312-695-3108 |
Oyinade Aderibigbe, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 111 W Washington St Ste 1801, Chicago, IL 60602 Phone: 312-926-3627 Fax: 312-694-9966 |
Dr. Noor Tazudeen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4700 N Marine Dr Ste 220, Chicago, IL 60640 Phone: 608-287-2658 |
News Archive
Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
Gilead Sciences, Inc. and Galapagos NV today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents.
Continuing to work during depressive illness may offer employees certain health benefits
The collaborative study between the University Of Melbourne and the Menzies Research Institute at the University of Tasmania is the first to estimate the long-term costs and health outcomes of depression-related absence as compared to individuals who continue to work among employees with depression in Australia.
Officials debate merits of medical marijuana as coping tool in pain fight
As access to medical marijuana becomes more widespread, officials are debating its use as a pain-coping treatment and are easing rules for the sick to use the drug, The Wall Street Journal reports. "The U.S. Department of Justice has said it will not generally prosecute ill people under doctors' care whose use of the drug complies with state rules. New Jersey will become the 14th state to allow therapeutic use of marijuana, and the number is likely to grow. Illinois and New York, among others, are considering new laws."
Lucideon and ReBioStent project partners to host Bioresorbable Materials for Medical Applications session at ESB 2015
Lucideon, the international materials technology company, along with its partners on the ReBioStent project, will be hosting a satellite session, "Bioresorbable Materials for Medical Applications", at the European Society of Biomaterials (ESB) conference 2015 in Krakow, Poland on the 2nd of September.
Chaotic genetic changes drive the growth of melanomas
Melbourne researchers have revealed how melanoma cells are flooded with DNA changes as this skin cancer progresses from early, treatable stages through to fatal end-stage disease.
› Verified 9 days ago
Internal Medicine
Pediatrics
Family Medicine
Psychiatry & Neurology
Emergency Medicine
Anesthesiology
Obstetrics & Gynecology
Surgery
Radiology
Pathology